Novel Strain Engineering and Development for Alternative Proteins Summit

Memo

Advancements in AI and ML have been paving the way for precision fermentation-derived alternative protein success. With the global microfluidics market expected to reach $23.7 million by 2033, coupled with opportunities where we saw Google partner with Ginkgo, EV Biotech and Shiru investing in alternative proteins of the future, now is an exciting time to spark innovation with novel alternative proteins. This is evident as the fermentation-derived alternative protein market is expected to excel at an annual growth of 14% from now until 2031 – with investments flooding in for strain engineering efforts for protein production, now is an exciting time to spark innovation with novel alternative proteins. The Novel Strain Engineering and Development for Alternative Proteins Summit draws on our esteemed Fermentation-Enabled Alternative Protein Series, shifting to a specialized focus on transforming your strain engineering and optimization by leveraging the power of microfluidics, ultra-high throughput, and advanced genetic tools.   URLs:Tickets: https://go.evvnt.com/2191592-2?pid=5569 Brochure: https://go.evvnt.com/2191592-3?pid=5569  Date and Time: On Tue, 26 Mar 2024 09:00 - Thu, 28 Mar 2024 15:00 Venue details: The Clift Royal Sonesta San Francisco, 495 Geary Street, San Francisco, California, 94102, United States Prices:Conference Only - Multinationals, Food and Beverage Biotech: USD 2749.00,Conference + 1 Workshop - Multinationals, Food and Beverage Biotech: USD 3298.00,Conference + 2 Workshops - Multinationals, Food and Beverage Biotech: USD 3847.00,Conference Only - Academic: USD 2349.00,Conference + 1 Workshop - Academic: USD 2798.00,Conference + 2 Workshops - Academic: USD 3247.00,Conference Only - Vendor: USD 3449.00,Conference + 1 Workshop - Vendor: USD 4098.00,Conference + 2 Workshops - Vendor: USD 4747.00 Speakers: Anssi Rantasalo, Co-Founder, Eniferbio, Daniel Winter, Protein Science Lead, All G Foods, David Block, Professor and Chair, UC Davis, Eduard Kerkhoven, Docent, Chalmers University, Hal Alper, Professor - Chemical Engineering, University of Texas at Austin, Héctor Garcia Martin, Data Science and Modeling Director, Lawrence Berkeley National Laboratory, Katia Merten-Lentz, Lawyer, Food Law Science and Partners, Luis Brandao, Senior Research Scientist, Bond Pet Foods, Maciej Hołówko, Head of Biofoundry, Nourish Ingredients, Marcus Hans, Director - Research and Development, Vivici, Neil Adames, Senior Scientist I, Strain Engineering, New Culture, Ondrej Halgas, Lead Protein Scientist, Liven Proteins, Peter Hans Bissinger, Chief Executive Officer, Lovely Day Foods, Ricardo Ekmay, Senior Vice President - Research and Development, Arbiom, Tamir Tuller, Founder and Chief Scientific Officer, Imagindairy, Tim Geistlinger, Chief Science Officer, Perfect Day, Yi-Hsuan Chiang, Director of Biology, Oobli, Zheng You, Principal Scientist, Tate and Lyle